Abstract
This study aims to assess the trends in the incidence rate of neurological disorders in developed and developing countries worldwide during 1990–2019. The age-standardized incidence rate (per 100000 persons) of neurological disorders was the primary outcome, extracted from the Global Burden of Disease database for 189 countries and territories from 1990 to 2019. Using the Human Development Index (HDI), countries were classified into developed (HDI ≥ 0.7) and developing (HDI < 0.7) groups. Longitudinal analysis was performed using the Latent Growth Model (LGM) to assess the change in the incidence rate of neurological disorders over time in these groups. In developed countries, the most increasing rate is related to depressive disorders, with a rising rate of 40.15 in 100000 every five years (p = 0.001). Alzheimer’s and dementia, Parkinson and multiple sclerosis are in the next rank, with increasing rates of 8.77, 1.24, and .02, respectively (all p < 0.001). Over time, the significant decreasing trend has been determined related to conducting disorder, attention-deficit and hyperactivity, meningitis, anxiety, and eating disorders, with the rates of − 13.92, − 4.96, − 2.7, − 1.6, and − 1.44, respectively (all p < 0.05). In developing countries, meningitis, conduct disorder, attention-deficit and hyperactivity, stroke, and autism spectrum showed a significant decreasing trend over time, with rates of − 15.45, − 5.84, − 2.56, − 1.86, and − 1.07, respectively (all p < 0.05). Headache disorder has the most increasing rate of 79.5, following depressive (rate 35.32), substance use (rate 14.99), anxiety (rate 7.18), and eating (rate 3.4) disorders. Also, Alzheimer’s and dementia, bipolar disorder, schizophrenia, Parkinson’s, brain and central nervous system cancer, and multiple sclerosis are in the next rank and had significant increasing trends (all p < 0.05). Given the high economic and social burden of neurological disorders, the rate of these diseases in most countries does not seem to have dropped remarkably. The heterogeneous incidence rate in some world countries seems to be due to underestimating and gaps in epidemiological information. It is necessary to provide exact registry systems for health policies, especially in developing countries.
Similar content being viewed by others
Data availability
Data and materials can be made available upon request.
References
Aslanyan S, Weir CJ, Lees KR, Reid JL, McInnes GT (2003) Effect of area-based deprivation on the severity, subtype, and outcome of ischemic stroke. Stroke 34(11):2623–2628
Avan A, Digaleh H, Di Napoli M, Stranges S, Behrouz R, Shojaeianbabaei G, Amiri A, Tabrizi R, Mokhber N, Spence JD (2019) Socioeconomic status and stroke incidence, prevalence, mortality, and worldwide burden: an ecological analysis from the Global Burden of Disease Study 2017. BMC Med 17(1):1–30
Barbalat G, Franck N (2020) Ecological study of the association between mental illness with human development, income inequalities and unemployment across OECD countries. BMJ Open 10(4):e035055
Cifuentes M, Sembajwe G, Tak S, Gore R, Kriebel D, Punnett L (2008) The association of major depressive episodes with income inequality and the human development index. Social Sci Med 67(4):529–539
Conceição P (2019) Beyond income, beyond averages, beyond today: inequalities in human development in the 21st Century. UNDP; New York, NY, USA: 2019. Human Development Report
Feigin VL, Forouzanfar MH, Krishnamurthi R, Mensah GA, Connor M, Bennett DA, Moran AE, Sacco RL, Anderson L, Truelsen T (2014) Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet 383(9913):245–255
Feigin VL, Nichols E, Alam T, Bannick MS, Beghi E, Blake N, Culpepper WJ, Dorsey ER, Elbaz A, Ellenbogen RG (2019) Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 18(5):459–480
Global Burden of Disease Collaborative Network (2019) Global Burden of Disease Study 2019 (GBD 2019) Results. Seattle, U. S. I. f. H. M. a. E. I., 2020. Available from http://ghdx.healthdata.org/gbd-results-tool
Godman B, Grobler C, Van-De-Lisle M, Wale J, Barbosa WB, Massele A, Opondo P, Petrova G, Tachkov K, Sefah I (2019) Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries. Exp Opin Pharmacother 20(18):2237–2255
Idring S, Lundberg M, Sturm H, Dalman C, Gumpert C, Rai D, Lee BK, Magnusson C (2015) Changes in prevalence of autism spectrum disorders in 2001–2011: findings from the Stockholm youth cohort. J Autism Dev Disord 45(6):1766–1773
Kalkonde YV, Alladi S, Kaul S, Hachinski V (2018) Stroke prevention strategies in the developing world. Stroke 49(12):3092–3097
Khazaei Z, Goodarzi E, Borhaninejad V, Iranmanesh F, Mirshekarpour H, Mirzaei B, Naemi H, Bechashk SM, Darvishi I, Sarabi RE (2020) The association between incidence and mortality of brain cancer and human development index (HDI): an ecological study. BMC Public Health 20(1):1–7
Lund C, Brooke-Sumner C, Baingana F, Baron EC, Breuer E, Chandra P, Haushofer J, Herrman H, Jordans M, Kieling C (2018) Social determinants of mental disorders and the Sustainable Development Goals: a systematic review of reviews. Lancet Psychiatry 5(4):357–369
Lynch J, Due P, Muntaner C, Smith GD (2000) Social capital—is it a good investment strategy for public health? J Epidemiol Commun Health 54(6):404–408
Mackenbach JP, Karanikolos M, Looman CW (2014) The rise of mortality from mental and neurological diseases in Europe, 1979–2009: observational study. BMC Public Health 14(1):1–12
Miller MN, Pumariega AJ (2001) Culture and eating disorders: a historical and cross-cultural review. Psychiatry Interpersonal and Biological Processes 64(2):93–110
Miranda-Filho A, Piñeros M, Soerjomataram I, Deltour I, Bray F (2017) Cancers of the brain and CNS: global patterns and trends in incidence. Neuro-oncology 19(2):270–280
Moghaddam VK, Dickerson AS, Bazrafshan E, Seyedhasani SN, Najafi F, Hadei M, Momeni J, Moradi G, Sarmadi M (2021) Socioeconomic determinants of global distribution of multiple sclerosis: an ecological investigation based on Global Burden of Disease data. BMC Neurol 21(1):1–11
Russell AE, Ford T, Williams R, Russell G (2016) The association between socioeconomic disadvantage and attention deficit/hyperactivity disorder (ADHD): a systematic review. Child Psychiatry Human Dev 47(3):440–458
Shah R, Wilkins E, Nichols M, Kelly P, El-Sadi F, Wright FL, Townsend N (2019) Epidemiology report: trends in sex-specific cerebrovascular disease mortality in Europe based on WHO mortality data. Eur Heart J 40(9):755–764
Smolina K, Wright FL, Rayner M, Goldacre MJ (2012) Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study. BMJ 344
Stephan B, Birdi R, Tang EYH, Cosco TD, Donini LM, Licher S, Ikram MA, Siervo M, Robinson L (2018) Secular trends in dementia prevalence and incidence worldwide: a systematic review. J Alzheimer's Dis 66(2):653–680
World Bank (2017) World bank country and lending groups: the world bank. Available: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
Wu SH, Woo J, Zhang X-H (2013) Worldwide socioeconomic status and stroke mortality: an ecological study. Int J Equity Health 12(1):1–11
Acknowledgements
The authors thank the Institute for Health Metrics and Evaluation (IHME) for providing the data.
Author information
Authors and Affiliations
Contributions
Conceptualization, N.B., H.A., and H.D; Acquisition of data, N.B., and H.A.; Methodology, analysis, N.B. and H.D.; Writing-original draft preparation, NB, and K.O.; Writing-review and editing, H.A., and H.D.; Administrative and supervision, H.A.
Corresponding author
Ethics declarations
Ethics approval
The Ethics Committee of Shahid Beheshti University of Medical Sciences approved the study (ethic code, IR.SBMU.RETECH.REC.1397.605).
Consent to participate
Not applicable.
Consent for publication
Not applicable.
Conflict of interest
The authors declare no competing interests.
Additional information
Responsible Editor: Lotfi Aleya
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Borumandnia, N., Majd, H.A., Doosti, H. et al. The trend analysis of neurological disorders as major causes of death and disability according to human development, 1990-2019. Environ Sci Pollut Res 29, 14348–14354 (2022). https://doi.org/10.1007/s11356-021-16604-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11356-021-16604-5